| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 13,414 | 26,775 | 45,622 | 76,507 |
| Accounts receivable | NaN | NaN | NaN | 0 |
| Inventory (related party transaction) | 0 | 174,745 | 174,788 | 174,788 |
| Less allowance for inventory obsolescence | NaN | -174,745 | NaN | NaN |
| Prepaid otcqb fee | 5,340 | 9,345 | 13,350 | 16,020 |
| Right of use assets | 0 | 0 | 0 | 0 |
| Total assets | 18,754 | 36,120 | 233,760 | 267,315 |
| Accounts payable | 0 | 0 | 0 | 0 |
| Lease liability | 0 | 0 | 0 | 0 |
| Unearned sales revenue | 0 | 1,860 | 1,860 | 1,860 |
| Unearned service revenue | 100,000 | 100,000 | 100,000 | 100,000 |
| Accrued legal fee | 0 | 0 | 0 | 7,760 |
| Total current liabilities | 100,000 | 101,860 | 101,860 | 109,620 |
| Due from the related party | 95,588 | 95,588 | 95,588 | 95,588 |
| Long-term liabilities | 189,250 | 189,250 | 189,250 | 189,250 |
| Less discount on long-term liabilities | -4,765 | -6,865 | -8,965 | -11,065 |
| Total liabilities | 380,073 | 379,833 | 377,733 | 383,393 |
| Common stock, 0.0001 par value, 300,000,000 shares authorized, 99,000,000 issued and outstanding at december 31, 2025 99,000,000 issued and outstanding at march 31, 2026 | 9,900 | 9,900 | 9,900 | 9,900 |
| Additional paid-in capital | 1,302,504 | 1,302,504 | 1,302,504 | 1,302,504 |
| Retained earnings | -1,673,722 | -1,656,117 | -1,456,377 | -1,428,481 |
| Total stockholders' equity | -361,319 | -343,713 | -143,974 | -116,079 |
| Total liabilities and stockholders' equity | 18,754 | 36,120 | 233,760 | 267,315 |
GOLDENWELL BIOTECH, INC. (GWLL)
GOLDENWELL BIOTECH, INC. (GWLL)